We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Wearable ReWalk Device Finds Partner in Japanese Robotics Firm
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Wearable ReWalk Device Finds Partner in Japanese Robotics Firm
BusinessFinanceMedical DevicesTechnology

Wearable ReWalk Device Finds Partner in Japanese Robotics Firm

Deanna Pogorelc
Deanna Pogorelc
Share
2 Min Read
health technology
SHARE

health technologyA robotic exoskeleton that was demonstrated for President Obama earlier this year as one of Israel’s most cutting-edge inventions is getting a boost from a Japan-based robotics manufacturer.

health technologyA robotic exoskeleton that was demonstrated for President Obama earlier this year as one of Israel’s most cutting-edge inventions is getting a boost from a Japan-based robotics manufacturer.

Yaskawa Electric Corporation has invested in and formed a strategic partnership with ARGO Medical Technologies, which makes a device called ReWalk that enables individuals with lower limb disabilities such as paraplegia to walk.

When it’s strapped on the body, the device uses computers and motion sensors to detect subtle changes in a person’s center of gravity, such as a forward tilt of the upper body. That triggers its motorized legs and power hip and knee movements, so that the user doesn’t have mess with tethers or switches to begin moving.

More Read

Tipping Point: Are Private Practice Doctors Becoming Extinct?
The Evolution of Medicare Telehealth Reimbursement
Health IT Gets Closer to the Cloud in the Mile-High City
CVS Kicks the Habit, with Implications for Consumer-Centered Healthcare
Reducing Healthcare Costs Through Company Wellness Plans

ARGO said Yaskawa made a capital investment in the company but didn’t say how much, referring to the investment only as the “largest single investment” for the company and part of its largest funding round to date. It will use that money to support the expansion of R&D and efforts to enhance the device’s design for streamlined manufacturing.

Yaskawa will also handle Asian distribution of ReWalk. The device comes in two models — one for use in rehabilitation centers and other for personal use by consumers. Both models are available in Europe and Israel; in the U.S., the ReWalk Personal is still awaiting regulatory approval, which a company rep said could come by the end of the year.

MedCity News reached out to ARGO’s rep to ask for more detail and will update this story with any information provided by the company.

TAGGED:ReWalk
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Why Music Gives The Brain A Workout -- AI-generated illustration
Why Music Gives The Brain A Workout
Infographics Wellness
October 14, 2026
A Hydration And Heat Guide For Youth Cheer -- AI-generated illustration
A Hydration And Heat Guide For Youth Cheer
Infographics
October 13, 2026
Flat editorial illustration: Core relationship is dual-track recovery where family support improves outcomes only when families m
Supporting a Loved One Through Addiction Recovery
Addiction Recovery
October 13, 2026
Flat editorial illustration: The article's core relationship is that substantial clinical testing of thymosin alpha-1 did not est
Thymosin Alpha-1 Got the Big Trials Most Peptides Never Get
Global Healthcare
October 12, 2026

You Might also Like

Forever Fix: Gene Therapy
Medical InnovationsTechnology

The Latest in Gene Therapy Research

May 10, 2013

Artificial Retina Approved for Sale in Europe

May 31, 2011

Report: Avoidable ‘Never Events’ Increase in Minnesota Hospitals

January 20, 2012

Global Size and Growth of Spine Surgery Market Segments

July 7, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?